Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05726175
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-13
First Post:
2023-01-30
Brief Title:
Disitamab VedotinRC48 Combined With PenpulimabAK105 for Neoadjuvant Treatment of HER2-low Breast Cancer
Sponsor:
West China Hospital
Organization:
West China Hospital
Organization Data
Organization:
West China Hospital
Class:
OTHER
Study ID:
RCVDBCIIR005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
West China Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Shuangyue Liu
Responsible Party Title:
Clinical Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
West China Hospital
Old Name:
None
Old Organization:
None